Cargando...
Managing Lung Cancer with Comorbid Interstitial Pneumonia
Systemic therapy for advanced non-small cell lung cancer (NSCLC) has dramatically changed in the latest 15 years. Molecular-targeted therapy has brought about an era of precision medicine, and immune checkpoint inhibitors have brought hope for a cure for advanced NSCLC. In the wake of this remarkabl...
Guardado en:
| Publicado en: | Intern Med |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
The Japanese Society of Internal Medicine
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7008037/ https://ncbi.nlm.nih.gov/pubmed/31534086 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2169/internalmedicine.3481-19 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|